Distribution of breakpoints induced by etoposide and X-rays along the CHO X chromosome

• Published in: Cytogenetic and Genome Research Vol. 104; no. 1-4; pp. 182 - 187
• Main Authors: Martínez-López, W., Folle, G.A., Cassina, G., Méndez-Acuña, L., Di-Tomaso, M.V., Obe, G., Palitti, F.
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.01.2004
• Subjects: Animals; CHO Cells - drug effects; CHO Cells - radiation effects; CHO Cells - ultrastructure; Chromatids - drug effects; Chromatids - radiation effects; Chromatids - ultrastructure; Chromosome Aberrations; Chromosome Breakage; Chromosome Mapping; Cricetinae; Cricetulus; DNA - drug effects; DNA - radiation effects; DNA Damage; Enzyme Inhibitors - toxicity; Etoposide - toxicity; Female; Low-LET Radiation; S Phase - drug effects; S Phase - radiation effects; Topoisomerase II Inhibitors; X Chromosome - drug effects; X Chromosome - genetics; X Chromosome - radiation effects; X Chromosome - ultrastructure
• ISBN: 3805577672; 9783805577670
• ISSN: 1424-8581; 1424-859X
• DOI: 10.1159/000077486

SORB (selected observed residual breakpoints) induced by ionizing radiation or endonucleases are often non-randomly distributed in mammalian chromosomes. However, the role played by chromatin structure in the localization of chromosome SORB is not well understood. Anti-topoisomerase drugs such as etoposide are potent clastogens and unlike endonucleases or ionizing radiation, induce DNA double-strand breaks (DSB) by an indirect mechanism. Topoisomerase II (Topo II) is a main component of the nuclear matrix and the chromosome scaffold. Since etoposide leads to DSB by influencing the activity of Topo II, this compound may be a useful tool to study the influence of the chromatin organization on the distribution of induced SORB in mammalian chromosomes. In the present work, we compared the distribution of SORB induced during S-phase by etoposide or X-rays in the short euchromatic and long heterochromatic arms of the CHO9 X chromosome. The S-phase stage (early, mid or late) at which CHO9 cells were exposed to etoposide or X-rays was marked by incorporation of BrdU during treatments and later determined by immunolabeling of metaphase chromosomes with an anti-BrdU FITC-coupled antibody. The majority of treated cells were in late S-phase during treatment either with etoposide or X-rays. SORB induced by etoposide mapped preferentially to Xq but random localization was observed for SORB produced by X-rays. Possible explanations for the uneven distribution of etoposide-induced breakpoints along Xq are discussed.